|
DNAJC8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.058400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.665000E-01 |
| Normal-vs-Stage2 |
7.790100E-02 |
| Normal-vs-Stage3 |
4.138200E-01 |
| Normal-vs-Stage4 |
8.645400E-01 |
| Stage1-vs-Stage2 |
1.136780E-01 |
| Stage1-vs-Stage3 |
6.545000E-01 |
| Stage1-vs-Stage4 |
8.659200E-01 |
| Stage2-vs-Stage3 |
4.083800E-01 |
| Stage2-vs-Stage4 |
1.832820E-01 |
| Stage3-vs-Stage4 |
5.537000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.068400E-01 |
| Normal-vs-AfricanAmerican |
7.055200E-01 |
| Normal-vs-Asian |
5.183200E-01 |
| Caucasian-vs-AfricanAmerican |
6.589000E-01 |
| Caucasian-vs-Asian |
8.172400E-01 |
| AfricanAmerican-vs-Asian |
6.663600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.809810E-01 |
| Normal-vs-Female |
5.613000E-01 |
| Male-vs-Female |
2.413900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.363800E-01 |
| Normal-vs-Extreme_Weight |
4.928200E-01 |
| Normal-vs-Obese |
5.159200E-01 |
| Normal-vs-Extreme_Obese |
1.148010E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.822600E-01 |
| Normal_Weight-vs-Obese |
9.151800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.609400E-01 |
| Extreme_Weight-vs-Obese |
9.792200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.007800E-01 |
| Obese-vs-Extreme_Obese |
3.744600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.019800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.409400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.413430E-01 |
| Normal-vs-Age(81-100Yrs) |
2.165400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.504800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.681800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.726400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.359600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.459600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.423800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.906800E-01 |
| Normal-VS-Type2 PRCC |
6.020400E-02 |
| Normal-VS-KIRP CIMP |
5.586200E-01 |
| Normal-VS-Unclassified PRCC |
5.875800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.377500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.227800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.188200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.262600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.799200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.186600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.867800E-01 |
| Normal-vs-N1 |
2.494800E-01 |
| Normal-vs-N2 |
5.467400E-01 |
| N0-vs-N1 |
9.758800E-01 |
| N0-vs-N2 |
9.494800E-01 |
| N1-vs-N2 |
9.070000E-01 |
|
|
